Oct
2026
Fiera Milano, Italy
Visit us
stand 1B94, Excipients&Fine Chemicals

Croda Pharma

Exhibitor at CPHI Milan 2026
About Us

Croda Pharma is a leading partner for the development of excipients and the supply of high purity materials for pharmaceutical formulations.

Croda Pharma’s formulation and regulation expertise enables the next generation of drug delivery systems. Croda Pharma offers high purity pharmaceutical excipients to enhance delivery, efficacy, and stability of actives as well as highly performing vaccine adjuvants and in-house formulation expertise to aid in navigating drug and vaccine formulation challenges. The company is focused on empowering biologics drug delivery, through its adjuvant systems, small molecule, protein, and nucleic acid delivery platforms. With a wide...

  • Country/Region:
    United Kingdom
  • On CPHI since:
    2015
  • Certificates:
    2
  • Employees:
    1000 - 4999
Company types
Manufacturer/Innovator
Primary activities
Animal Health
Custom Manufacturing/Custom Synthesis
Excipients Manufacturer
Fine Chemicals Company
Contact info
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 1B94, Excipients&Fine Chemicals

Products Featured at CPHI Milan 2026

  • Adjuvant Systems for Vaccines

    Product Adjuvant Systems for Vaccines

    We enable next-generation vaccine development through a diverse portfolio of world-leading vaccine adjuvants, immunomodulators and adjuvant formulations.
    We passionately develop new adjuvant technologies and partner to develop the vaccines of tomorrow.
    Our extensive expertise in immunology and fo...
  • Bioprocessing solutions and excipients for protein therapeutic formulations

    Product Bioprocessing solutions and excipients for protein therapeutic formulations

    From excipients for protein therapeutic formulations, to innovating solutions for bioprocessing, we have decades of experience in protein delivery. TALK TO US about our latest launches: Virodex™ detergent range, a sustainable alternative to Triton™ X-100 for viral inactivation and cell lysis. Plus, Tween...
  • Excipients for Consumer Health

    Product Excipients for Consumer Health

    Croda Pharma's Consumer Health offering combines our technical expertise with regulatory knowledge to help our customers market innovative products with consumer relevant claims, alongside supporting formulation development challenges within the Consumer Health market.
    Our excipient solutions support ...
  • High purity excipients for small molecule delivery

    Product High purity excipients for small molecule delivery

    We offer high purity, multi-compendial, pharmaceutical excipients for small molecule drug delivery. Our portfolio of high purity excipient products and speciality chemistries solve formulation challenges and enhance drug delivery across a variety of administration routes and dosage forms. We are market le...
  • Nucleic Acid Delivery for Vaccines and Next-Gen Therapeutics

    Product Nucleic Acid Delivery for Vaccines and Next-Gen Therapeutics

    Avanti Polar Lipids, part of Croda Pharma, develops innovative lipids of unparalleled purity to solve the stability and delivery issues associated with mRNA for use in vaccines and next-generation therapeutics.
    We develop and manufacture highly specialised lipids used in Lipid Nanoparticle (LNP) deliv...

Croda pharma Resources (1)

  • Brochure Addressing the challenges of vaccine formulation

    To this day, our focus has been to successfully develop, manufacture and market high-quality adjuvants for our pharmaceutical customers. This heritage makes our vaccine adjuvants unique in the industry. A heritage we are proud of. 

    Our industry-leading, Alhydrogel®, Adju-Phos® and Quil-A® are widely recognised in the vaccine industry for their unmatched track record when it comes to a proven history of safe and effective use.